Concepedia

Dario Speziale

DS

Statistics

Publications

6

Citations

226

H-Index

6

Active since

2020

Affiliations

Roche (Switzerland)(Current)

Dario Speziale is an author at Roche (Switzerland) specializing in tumor immunology, immunodominance, and tumor immunity.

Top concepts

Publications per year

2020–2024

6

Publications

6

The Type II Anti‐CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model

Anthony Marinov, Haowei Wang, Sheldon Bastacky et al. · Arthritis & Rheumatology · 2020 · 61 citations · Full text

Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity

Eva Sum, Moritz Rapp, Philipp Fröbel et al. · Clinical Cancer Research · 2021 · 57 citations · Full text

Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity

Caleb Stoltzfus, Ramya Sivakumar, Leo Kunz et al. · Frontiers in Immunology · 2021 · 35 citations · Full text

Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine model

Floriana Cremasco, Elena Menietti, Dario Speziale et al. · PLoS ONE · 2021 · 32 citations · Full text

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy

Johannes Sam, Thomas Höfer, Christine Kuettel et al. · Blood · 2024 · 31 citations · Full text

, , +19

1–5 of 6